Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three licensed injection sites for a semaglutide shot are the abdomen, the front of the thigh, and the outer upper arm. All three are suitable for subcutaneous (under-the-skin) injection, and the choice between them comes down to your comfort, your routine, and whether you need someone else to help. These are prescription-only medicines — a prescriber assesses your suitability before treatment begins, and your Patient Information Leaflet gives the definitive technique guidance for your specific pen. The NHS medicines page for semaglutide confirms all three sites, as does the official Summary of Product Characteristics published on the eMC.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every site delivers the medicine to subcutaneous tissue (the thin layer of fat just beneath the skin) so absorption differences between a healthy abdomen, thigh, and upper arm are minimal in practice. What actually affects your experience is consistency of rotation and skin condition at the point of injection. A question our prescribers hear most weeks is whether one site "works better" than another; the honest answer is that technique and rotation matter more than which of the three you pick.
The decision, then, is really a practical one. If you want a full breakdown of each approved location and how to choose between them, our guide on where semaglutide should be injected covers the options in detail. The abdomen tends to suit people who self-inject without help: there is more accessible surface area, it is easy to see clearly, and you can pinch the skin with one hand while injecting with the other. The front of the thigh is similarly self-accessible and a good alternative if you find the abdomen uncomfortable. The outer upper arm (specifically the fatty area towards the back) is harder to reach alone, but works well with some guidance on positioning, and many people use it comfortably with a partner's help.
Whichever site you start with, commit to a rotation plan. Injecting into exactly the same spot week after week can cause lipohypertrophy (small fatty lumps under the skin) which slows absorption and can make injections uncomfortable. Vary the specific point within a site, and cycle through sites across consecutive weeks.
If you are using the abdomen, aim for the area to the left or right of the navel, staying at least five centimetres clear of it. The lower abdomen (below the waist, above the hip) offers a generous and consistent amount of subcutaneous tissue for most people. Avoid the beltline itself, any area that is currently bruised, and skin that feels hardened or tender from a previous injection.
Clean the skin with an alcohol swab and let it dry fully before injecting, wet skin stings more and can introduce moisture under the needle. Medical-grade alcohol swabs are straightforward to keep alongside your pen. Pinch a fold of skin gently, insert the pen at a 90-degree angle (or 45 degrees if you have very little subcutaneous tissue), press the injection button, and hold in place for the count your leaflet specifies (usually around ten seconds) to ensure the full dose is delivered before withdrawing.
For a more detailed look at the exact technique steps, our guide on how to inject semaglutide walks through the process in full. Your Patient Information Leaflet and your prescriber's instructions always take precedence over any general guide.
The front of the thigh (the middle third, roughly mid-way between the knee and the hip) is easy to access when sitting, which some people find steadier than standing at a bathroom mirror. Avoid the inner thigh (thinner skin, more sensitive) and stay away from the knee and hip joints. The same five-centimetre navel rule does not apply here, but you should still move your injection point at least two to three centimetres from last week's spot within the thigh.
The outer upper arm site sits in the fatty area at the back-outside of the arm, roughly halfway between the shoulder and elbow. Most people cannot self-inject here accurately without assistance; if you are injecting alone, the abdomen or thigh is more reliable. For those with a helpful partner, the upper arm works well as a third rotation point and gives the skin at other sites a longer rest. The pen goes in perpendicular to the skin, there is no need to pinch the arm if sufficient subcutaneous tissue is present, though technique varies by individual.
Wherever you inject, store your pen correctly between doses. Semaglutide pens require refrigeration between 2°C and 8°C, with a limited room-temperature window once in use, your Patient Information Leaflet gives the exact figures. If you are travelling, flying with a Wegovy pen is permitted with some planning around how you keep it cool.
Mild redness, itching or a small raised area at the injection site is common and usually fades within a day. Persistent swelling, firm lumps, or a site that stays painful between doses are worth mentioning to your prescriber, do not keep injecting into the same spot. The NHS notes that injection-site reactions are among the more frequently reported effects with semaglutide, alongside the gastrointestinal side effects (nausea, stomach discomfort, loose stools) that tend to be most noticeable after starting or a dose increase.
If you notice more serious symptoms (severe abdominal pain that moves towards the back, a significant allergic reaction, or anything that concerns you) seek medical attention promptly and report it via the MHRA's Yellow Card scheme. That reporting system is how the UK monitors real-world safety of medicines, including those under additional surveillance like Wegovy.
Getting the site and rotation right is a small habit that pays off across months of treatment. For an overview of how semaglutide works as a weight-management medicine, the Wegovy treatment page covers the broader picture. And if you have questions about your specific situation, our prescribers can advise through a free consultation, it is a good place to raise anything your leaflet does not quite answer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.